GLOBAL LOW MOLECULAR WEIGHT HEPARIN MARKET 2019 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2024

Mar 2019 124

Delivery of the Report will take 2-3 working days once order is placed.

Synopsis

Low Molecular Weight Heparin (LMWHs) is derived from UFH (Unfractionated heparin) by such processes as chemical degradation, enzymatic depolymerisation and gamma-radiation cleavage.
Natural heparin consists of molecular chains of varying lengths, or molecular weights. Chains of varying molecular weights, from 5000 to over 40,000 Daltons, make up polydisperse pharmaceutical-grade heparin. LMWHs, in contrast, consist of only short chains of polysaccharide. LMWHs are defined as heparin salts having an average molecular weight of less than 8000 Da and for which at least 60% of all chains have a molecular weight less than 8000 Da.

Scope of the Report:
In 2016, in term of volume, the global Low molecular weight heparin market is led by china, capturing about 49.57% of global low molecular weight heparin production. In term of revenue, USA is the second’s largest market with the share of 30.49%.
At present, the major manufacturers of Low Molecular Weight Heparin are Aspen, Sanofi-aventis, Pfizer, Opocrin, CSBIO, Dongying Tiandong Pharmaceutical, Changzhou Qianhong Bio-pharma, Techdow, Yantai Dongcheng Pharmaceutical Group, etc. Aspen, Sanofi-aventis and Pfizer are industry-leading manufacturers of top-quality Low Molecular Weight Heparins.
China is a big low molecular weight heparin production country, especially Heparin API, but it is not strong country. According to our research and analysis, manufacturers from United States and Europe are the major leaders in the international market of low molecular weight heparin. Manufacturers from China are immature in technology. There is large space in the China market, as well as big gap between international brands and local brands on price.
In application, low molecular weight heparin downstream is wide and recently low molecular weight heparin has acquired increasing significance in various fields of treatment of venous thromboembolism, complications of pregnancy, cardioversion of atrial fibrillation/flutter and others.
Globally, the low molecular weight heparin market is mainly driven by growing demand for treatment of venous thromboembolism which accounts for nearly 65.24% of total downstream consumption of low molecular weight heparin in global.
The worldwide market for Low Molecular Weight Heparin is expected to grow at a CAGR of roughly 5.6% over the next five years, will reach 380 million US$ in 2024, from 270 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Low Molecular Weight Heparin in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
- Aspen
- Sanofi-aventis
- Pfizer
- Opocrin
- CSBIO
- Dongying Tiandong Pharmaceutical
- Changzhou Qianhong Bio-pharma
- Techdow
- Yantai Dongcheng Pharmaceutical Group

Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
- Enoxaparin
- Dalteparin
- Tinzaparin
- Fraxiparine

Market Segment by Applications, can be divided into
- Treatment of Venous Thromboembolism
- Complications of Pregnancy
- Cardioversion of Atrial Fibrillation/Flutter
- Others

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Low Molecular Weight Heparin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Low Molecular Weight Heparin, with price, sales, revenue and global market share of Low Molecular Weight Heparin in 2017 and 2018.
Chapter 3, the Low Molecular Weight Heparin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Low Molecular Weight Heparin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Low Molecular Weight Heparin market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Low Molecular Weight Heparin sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

Related reports :

(Aug 19)

Pemetrexed (brand name Alimta) is a chemotherapy drug manufactured and marketed by Eli Lilly and Company. Its indications are the treatment ...

(Aug 19)

Drug integrated polymer fibers are used to create implantable textile devices using a combination of resorbable as well as non-resorbable po...

(Aug 19)

Fast-dissolving Tablets is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs dif...

(Aug 19)

Fast-disintegrating Tablets is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs...

(Aug 19)

Rapid-dissolving Tablets is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs di...

(Aug 19)

Mouth-dissolving Tablets is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs di...

GLOBAL LOW MOLECULAR WEIGHT HEPARIN MARKET 2019 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2024

Global Info Research

Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medicine and Pharmacy market as per your needs. Get the best of Medicine and Pharmacy research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

Buy Any Report Avail 15% Discount. Coupon Code: AUG15

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy